Effect of Bezafibrate on Very Long Chain Fatty Acid Metabolism in Men With X-linked Adrenoleukodystrophy (X-ALD).
Phase of Trial: Phase II
Latest Information Update: 09 Aug 2011
At a glance
- Drugs Bezafibrate (Primary)
- Indications Adrenoleucodystrophy
- Focus Pharmacodynamics
- Acronyms BEZA
- 09 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Aug 2011 Actual end date (Aug 2011) added as reported by ClinicalTrials.gov.
- 02 Aug 2010 New trial record